NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

HyGro,

So peer reviewers are the blind leading the blind?; ). This trial, like Kat’s Cure had patients respond that had greater tumor burden. As a matter of fact those that had second resections and crossed over faired worse than those who crossed over without resection.
The science of the treatment and it’s targets wins here but keep spinning to your heart’s content. Just be careful not to fall off that merry-go-round. LOL!; ). Best wishes.